Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 4
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean abdel hakam i[au] (1 results)?
Dysregulated Metabolic Pathways in Subjects with Obesity and Metabolic Syndrome.
Mir FA, Ullah E, Mall R, Iskandarani A, Samra TA, Cyprian F, Parray A, Alkasem M, Abdalhakam I, Farooq F, Abou-Samra AB. Mir FA, et al. Among authors: abdalhakam i. Int J Mol Sci. 2022 Aug 29;23(17):9821. doi: 10.3390/ijms23179821. Int J Mol Sci. 2022. PMID: 36077214 Free PMC article.
Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome.
Mir FA, Mall R, Iskandarani A, Ullah E, Samra TA, Cyprian F, Parray A, Alkasem M, Abdalhakam I, Farooq F, Abou-Samra AB. Mir FA, et al. Among authors: abdalhakam i. Front Endocrinol (Lausanne). 2022 Jul 22;13:937089. doi: 10.3389/fendo.2022.937089. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937842 Free PMC article.
Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.
Suleiman N, Alkasem M, Al Amer Z, Salameh O, Al-Thani N, Hamad MK, Baagar K, Abdalhakam I, Othman M, Dughmosh R, Al-Mohanadi D, Al Sanousi A, Bashir M, Chagoury O, Taheri S, Abou-Samra AB. Suleiman N, et al. Among authors: abdalhakam i. Trials. 2022 Jun 16;23(1):504. doi: 10.1186/s13063-022-06334-5. Trials. 2022. PMID: 35710428 Free PMC article.
Dapagliflozin, as Add-on Therapy in Type 2 Diabetes Patients, Is Associated With a Reduction in Albuminuria and Serum Transaminase Levels.
Benjamin S, Ramanjaneya M, Butler AE, Janjua I, Paramba F, Palaki J, Kubaisi AA, Chandra P, Abdalhakam I, Massodi NA. Benjamin S, et al. Among authors: abdalhakam i. Front Clin Diabetes Healthc. 2021 Oct 12;2:733693. doi: 10.3389/fcdhc.2021.733693. eCollection 2021. Front Clin Diabetes Healthc. 2021. PMID: 36994321 Free PMC article.
Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide.
Suleiman N, Alkasem M, Hassoun S, Abdalhakam I, Bettahi I, Mir F, Ramanjaneya M, Jerobin J, Iskandarani A, Samra TA, Chandra P, Skarulis M, Abou-Samra AB. Suleiman N, et al. Among authors: abdalhakam i. BMJ Open Diabetes Res Care. 2021 Nov;9(2):e002039. doi: 10.1136/bmjdrc-2020-002039. BMJ Open Diabetes Res Care. 2021. PMID: 34785564 Free PMC article.